Both in Pharmaceuticals
SCYNEXIS vs Impact BioMedical
Over the past year SCYX returned −23.8% and IBO returned −39.0%; their daily moves had a correlation of 0.03.
SCYX −23.8% IBO −39.0%Growth of $1, one year, split-adjusted
| Metric | SCYX | IBO |
|---|---|---|
| Price | $3.84 | $4.10 |
| Market cap | $38.2M | $35.0M |
| Today | −2.54% | +1.99% |
| 1 month | −20.7% | −12.4% |
| 6 months | −51.1% | −48.8% |
| Year to date | −24.1% | −35.7% |
| 1 year | −24.8% | −39.0% |
| Revenue growth (YoY) | −82.8% | −57.1% |
| Gross margin | 100.0% | −533.3% |
| Net margin | 3147.7% | −23300.0% |
| P/E (TTM) | — | 44.4× |
| Price / sales | 2.0× | 1,000.8× |
| Net cash | $54.1M | $10.0K |
| Dividend yield | — | — |
| Volatility (60d) | 63.6% | 736.6% |
| Short % of float | 4.7% | 2.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).